The increased use and spend associated with compounded medications has become a hot-button topic in recent months as payers have noticed these therapies creeping into their top 10 drug spend lists and Holding Co. reported that utilization among its clients jumped 30% in 2013 ( 4/18/14, p. 1). Similarly, Catamaran Corp. witnessed a five-fold increase in annual spending on compounded medications across its commercial book of business from 2012 to 2013.
As a result, Catamaran has put together a “robust menu of services” that can be tailored to meet clients’ specific needs. The company on June 16 unveiled the new Safe & Effective Compound Use Reassurance Effort (SECURE) program dedicated solely to addressing compounded medications from both a clinical and a financial perspective.
continue to read here
As a result, Catamaran has put together a “robust menu of services” that can be tailored to meet clients’ specific needs. The company on June 16 unveiled the new Safe & Effective Compound Use Reassurance Effort (SECURE) program dedicated solely to addressing compounded medications from both a clinical and a financial perspective.
continue to read here
No comments:
Post a Comment